Acadia Pharmaceuticals Inc.

This study tests the long-term safety of a nasal spray called carbetocin for people with Prader-Willi syndrome who experience severe, constant hunger (hyperphagia). About 160 participants who completed a previous study will receive the spray three times daily. The goal is to see …

This study tests the long-term safety of an experimental drug, ACP-204, for treating psychosis (hallucinations or delusions) in people with Lewy body dementia. About 126 adults who completed a prior study will take the drug for 52 weeks. The main goal is to see what side effects …

This study tests the long-term safety of a drug called ACP-204 for people with Alzheimer's disease who also have psychosis (hallucinations or delusions). It lasts 52 weeks and includes 752 adults aged 55 to 95 who already completed a previous study of the same drug. The main goal…

This study tests a nasal spray called carbetocin to see if it can reduce the intense, constant hunger (hyperphagia) that people with Prader-Willi syndrome experience. About 170 people aged 5 to 30 will receive either the spray or a placebo for 12 weeks. The main goal is to measur…